Related Experiment Videos

Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor

D H Teng1, W L Perry, J K Hogan

  • 1Myriad Genetics, Inc., Salt Lake City, Utah 84108, USA. tengd@myriad.com

Cancer Research
|October 23, 1997
PubMed

Insights

Mutations in the MKK4 gene, crucial for cell signaling, were found in approximately 3% of human cancer cell lines. These MKK4 alterations may indicate its role in suppressing tumor growth and metastasis.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Mitogen-activated protein kinases (MAPK) are key regulators of cellular processes.
  • The MKK4 (MAPK kinase 4) pathway is involved in stress- and cytokine-induced apoptosis.
  • MKK4 links upstream MEKK1 to downstream stress-activated protein kinase (SAPK)/JNK1 and p38 MAPK.

Purpose of the Study:

  • To investigate the role of MKK4 in human cancers.
  • To identify mutations and deletions in the MKK4 gene in various cancer cell lines.

Main Methods:

  • Analysis of human tumor cell lines for homozygous deletions in the MKK4 locus.
  • Screening of cancer cell lines for MKK4 sequence variants (nonsense and missense mutations).
  • In vitro biochemical assays to assess the functionality of altered MKK4 proteins.

Main Results:

  • Homozygous deletions of MKK4 were identified in pancreatic and lung carcinoma cell lines.
  • Five MKK4 sequence variants (2 nonsense, 3 missense) were found in 88 human cancer cell lines.
  • Approximately 3% of analyzed cell lines (6 of 213) showed MKK4 coding mutations.
  • Four of five altered MKK4 proteins were non-functional in phosphorylating stress-activated protein kinase when stimulated by MEKK1.

Conclusions:

  • MKK4 alterations are present in a subset of human cancers.
  • Functional MKK4 mutations suggest a potential role as a tumor suppressor.
  • MKK4 may inhibit tumorigenesis and metastasis in specific cell types.

Related Concept Videos